1Shiratori K, Takeuchi T, Satake K, et al. Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan. Panc
2Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol, 2004, 99:1605-1616.
3Uden S, Bilton D, Nathan L, et al. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther, 1990, 4:357-371.
4Apte MV, Keogh GW, Wilson JS. Chronic pancreatitis:complications and management. J Clin Gastroenterol, 1999,29:225-240.
5Pap A. Pancreatic head mass: how can we treat it? Chronic pancreatitis: conservative treatment. JOP, 2000, 1 (3 Suppl. ):143-153.
6Eisenach JC, Carpenter R, Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain, 2003,101: 89-95.
7Basso D, Panozzo MP, Fabris C, et al. Oxygenderived free radicals in patients with chronic pancreatic and other digestive disease.J Clin Pathol, 1990, 43: 403-405.
8Schoenberg MH, Buchler M, Pietrzyk C, et al. Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas, 1995, 10:36-43.
9Banks PA, Hughes M, Ferrante M, et al. Does allopurinol reduce pain of chronic pancreatitis? Int J Pancretol, 1997, 22:171-176.
10Malfertheiner P, Mayer D, Buchler M, et al. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut, 1995, 36:450-445.
